Skip to content
thestock.space

On 6 Nov 2026, Riddhi Siddhi Gluco Biols was priced at ₹656.20, or 32.0× trailing earnings, against an industry P/E of 14.4×, and the shares are 24% below their 52-week high. Its ROCE of 2.8% is the lowest among the 7 largest Agricultural Inputs peers, and sales grew 11% a year over 3 years, though net profit is above operating profit, which points to a one-off gain. Its dividend yield is 0.4%, and debt is 0.18× equity. It is a small-cap company with a market cap of ₹468 Cr, ranked 39th of 72 Agricultural Inputs companies by market cap; the shares rose 24% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹682.50
Day high
₹699.00
Day low
₹636.95
Prev. close
₹692.70
Volume
204

Health check

2 good · 3 to check
  • ReturnsAhead

    +24.2% over a year, better than 7 of 7 peers.

  • Price tagDistorted

    A one-off gain inflates profit, so P/E isn’t comparable right now.

  • GrowthStrong

    Sales +11.0% a year over 3 years.

  • ProfitabilityWeak

    ROCE 2.8% vs peer median 20.9%.

  • Balance sheetStretched

    Debt 0.18× equity, interest covered 2.8×, Piotroski 3 of 9.

  • Red flags5 to check

    Return on equity is low at −0.3%.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Agricultural Inputs

71 listed peers. Screen the industry

Small cap

₹468 Cr, #39 of 72 in its industry by size.

Defensive

Beta 0.65 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹171 Cr · profit ₹14 Cr
Market cap
₹468 Cr
Small cap
P/E
32.0
Industry 14.4
Price to book
0.31
Peers 4.28
Dividend yield
0.43%
ROE
−0.3%
Peers 16.2%
ROCE
2.8%
Peers 20.9%
Debt to equity
0.18
Debt ₹283 Cr
EPS (TTM)
₹20.51
OPM (TTM)
−8.6%
Net margin 8.7%
Sales growth
−41.9%
Latest quarter vs a year ago
Profit growth
−60.5%
Latest quarter vs a year ago
Price to sales
2.73
EV/EBITDA −45.2

Strengths and risks

Risks to check

  • Return on equity is low at −0.3%.
  • Quarterly profit down 60.5% on a year ago.
  • Quarterly sales down 41.9% on a year ago.
  • Net profit is above operating profit, so a one-off gain is likely flattering earnings.
  • P/E of 32.0 against an industry P/E of 14.4.

No standout strengths in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Riddhi Siddhi Gluco Biols

Riddhi Siddhi Gluco Biols Limited trades in agriculture and metal commodities in India. The company operates through Wind Power Generation, Trading Business, Paper Reprocessing, and Real Estate Business segments. It is involved in the generation and sales of wind power, and the sale of packaged water bottles, as well as engages in the sale of trading goods. The company was incorporated in 1990 and is based in Ahmedabad, India. Riddhi Siddhi Gluco Biols…

Headquarters
Ahmedabad
Employees
9
Sector
Basic Materials
ISIN
INE249D01019

Price range

52 weeks

₹405.00₹861.95

Today

₹636.95₹699.00
Avg volume (3M)
874
1-year return
plus 24.2%
From 52-week high
minus 23.9%

Peers · Agricultural Inputs

Capital-heavy industry columns

Company
COROMANDELCoromandel International1,824.00minus 4.00%53,72434.517.020.9%9.4%0.1110.2%minus 12.4%
FACTFertilisers and Chemicals Travancore750.25minus 1.24%48,547–703.514.2%0.0%2.950.0%minus 15.3%
UPLUPL534.90plus 1.60%45,21423.96.09.9%20.0%0.83−1.2%minus 28.0%
PIINDPI Industries1,735.00minus 1.98%26,32130.013.114.7%24.2%0.031.1%minus 51.9%
SUMICHEMSumitomo Chemical India328.95plus 0.34%16,41929.421.021.0%20.3%0.02−2.6%minus 34.4%
CHAMBLFERTChambal Fertilizers & Chemicals384.70minus 0.91%15,4138.15.721.8%13.7%0.16−9.2%minus 19.4%
BAYERCROPBayer Cropscience3,316.30plus 0.48%14,90420.015.427.9%16.0%0.033.6%minus 31.7%
RIDDHIRiddhi Siddhi Gluco Biols656.20minus 5.27%46832.0–2.8%−8.6%0.1811.0%plus 24.2%
Median of 7 peers–−0.91%26,32126.615.420.9%16.0%0.110.0%−28.0%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
15532.140.19.189.9
15530.545.617.192.5
−0.31.6−5.5−8.1−2.7
−0.2%4.8%−13.8%−89.0%−3.0%
21.222.114.31117
3.75.14.24.56.2
2.12.12.122.3
15.116.52.5−3.65.8
36.6%7.0%84.2%−38.2%34.1%
8.313.9−1.2−25.53.3
11.2719.29-1.81-45.924.21

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+11.0%
ROE
−0.3%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
172268135235
–+55.4%minus 49.5%+74.2%
153262132247
19.25.93−11.8
11.2%2.2%2.2%−5.0%
66.373.885.566.5
7.68.89.616.9
30.110.78.58.2
0.64.61.10.9
48.464.771.530.5
31.1%11.6%11.8%33.2%
−55.546.75.2−4.5
––minus 88.9%minus 186.1%
-119.1061.53-17.07-17.15

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
7.17.17.17.1
1,4251,5301,5421,502
8172.8101283
17916413599.4
1,6921,7741,7841,891
392382434426
209301313606
12.748.13.1110
1,0791,0421,035749
1,6921,7741,7841,891

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
0.58.9−28.3−9.2
8.32120.6−22.4
1.9−40.67.6140
10.8−10.7−0.1108
−0.3−13.4−48.7−0.3
0.2−4.5−77−9.6
−0.7−1.1−2.1−2.1

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you